- Release Date: 17/11/21 08:25
- Summary: Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
- Price Sensitive: Yes
- Download Document 134.39KB
- Forums
- ASX - By Stock
- ATX
- Ann: Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
ATX
amplia therapeutics limited
Add to My Watchlist
9.46%
!
20.3¢

Ann: Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.3¢ |
Change
0.018(9.46%) |
Mkt cap ! $97.29M |
Open | High | Low | Value | Volume |
19.0¢ | 20.5¢ | 19.0¢ | $978.4K | 4.916M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3060 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 30400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 338497 | 0.195 |
16 | 589533 | 0.190 |
12 | 574258 | 0.185 |
15 | 1562099 | 0.180 |
17 | 1384939 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 45249 | 1 |
0.205 | 259489 | 9 |
0.210 | 348452 | 11 |
0.215 | 300000 | 3 |
0.220 | 529263 | 4 |
Last trade - 15.59pm 08/08/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |